| Price | 13,800.00p on 02-12-2025 at 19:35:13 |
|---|---|
| Change | -36.00p -0.26% |
| Buy | 13,758.00p |
| Sell | 13,756.00p |
| Last Trade: | Unknown 32,418.00 at 13,701.6074p |
| Day's Volume: | 1,678,650 |
| Last Close: | 13,800.00p |
| Open: | 13,714.00p |
| ISIN: | GB0009895292 |
| Day's Range | 13,648.00p - 13,820.00p |
| 52wk Range: | 9,574.00p - 14,206.00p |
| Market Capitalisation: | £213.94b |
| VWAP: | 13,764.89801p |
| Shares in Issue: | 1.55b |
Astrazeneca (AZN) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 32,418 | 13,701.6074p | Ordinary Currency Conversion |
17:01:52 - 02-Dec-25 |
| Buy* | 333 | 13,800.00p | SI Trade Negotiated Trade |
16:48:45 - 02-Dec-25 |
| Buy* | 5,397 | 13,800.00p | SI Trade Negotiated Trade |
16:48:44 - 02-Dec-25 |
| Sell* | 13,675 | 13,771.447p | SI Trade Suspected SELL Trade |
16:47:10 - 02-Dec-25 |
| Buy* | 41 | 13,800.00p | Automatic Execution |
16:38:17 - 02-Dec-25 |
| Buy* | 1 | 13,800.00p | SI Trade |
16:35:29 - 02-Dec-25 |
| Buy* | 3 | 13,800.00p | SI Trade |
16:35:29 - 02-Dec-25 |
| Buy* | 5 | 13,800.00p | SI Trade |
16:35:29 - 02-Dec-25 |
| Buy* | 28 | 13,800.00p | SI Trade |
16:35:29 - 02-Dec-25 |
| Buy* | 633 | 13,800.00p | SI Trade |
16:35:29 - 02-Dec-25 |
Astrazeneca (AZN) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 1st Dec 2025 3:05 pm | RNS | Block listing Interim Review |
| 1st Dec 2025 3:00 pm | RNS | Total Voting Rights |
| 26th Nov 2025 7:00 am | RNS | Imfinzi approved in US for early gastric cancer |
| 24th Nov 2025 7:00 am | RNS | AstraZeneca manufacturing investment in Maryland |
| 20th Nov 2025 7:00 am | RNS | Koselugo (selumetinib) approved in the US |
| 17th Nov 2025 3:00 pm | RNS | Holding(s) in Company |
| 14th Nov 2025 11:00 am | RNS | Director/PDMR Shareholding |
| 10th Nov 2025 3:00 pm | RNS | Director/PDMR Shareholding |
| 6th Nov 2025 7:00 am | RNS | 9M and Q3 2025 results |
| 3rd Nov 2025 4:00 pm | RNS | Result of General Meeting |
